Allianz SE lifted its stake in shares of Stryker Corporation (NYSE:SYK – Free Report) by 729.4% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 7,465 shares of the medical technology company’s stock after purchasing an additional 6,565 shares during the quarter. Allianz SE’s holdings in Stryker were worth $2,056,000 as of its most recent SEC filing.
Other institutional investors have also added to or reduced their stakes in the company. International Assets Investment Management LLC raised its stake in Stryker by 1,432.8% in the third quarter. International Assets Investment Management LLC now owns 25,000 shares of the medical technology company’s stock valued at $6,885,000 after purchasing an additional 23,369 shares in the last quarter. Amundi boosted its position in Stryker by 18.3% during the second quarter. Amundi now owns 1,246,353 shares of the medical technology company’s stock valued at $392,402,000 after buying an additional 192,447 shares during the period. The Manufacturers Life Insurance Company boosted its holdings in Stryker by 8.2% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 859,544 shares of the medical technology company’s stock valued at $270,642,000 after acquiring an additional 65,333 shares during the period. Veritas Asset Management LLP bought a new position in shares of Stryker in the second quarter worth approximately $168,057,000. Finally, Bank of America Corp DE bought a new stake in Stryker during the 2nd quarter valued at $1,404,284,000. Hedge funds and other institutional investors own 77.09% of the company’s stock.
Insiders Place Their Bets
In related news, Director Ronda Stryker sold 550,000 shares of the business’s stock in a transaction on Friday, November 6th. The stock was sold at an average price of $325.32, for a total transaction of $178,926,000.00. Following the completion of the transaction, the director owned 1,701,375 shares in the company, valued at $553,491,315. The trade was a 24.43% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 4.60% of the stock is owned by company insiders.
Stryker Stock Down 1.0%
Stryker (NYSE:SYK – Get Free Report) last released its earnings results on Thursday, October 29th. The medical technology company reported $3.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.55 by ($0.03). The business had revenue of $6.52 billion for the quarter, compared to analysts’ expectations of $6.62 billion. Stryker had a return on equity of 23.74% and a net margin of 13.78%. The business’s revenue for the quarter was up 7.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $3.19 EPS. On average, equities research analysts forecast that Stryker Corporation will post 14.85 EPS for the current year.
Wall Street Analyst Weigh In
Several analysts recently weighed in on the stock. Raymond James Financial reiterated an “outperform” rating and issued a $323.00 price target (down from $370.00) on shares of Stryker in a report on Friday, October 30th. Leerink Partners lowered their target price on shares of Stryker from $403.00 to $353.00 and set an “outperform” rating for the company in a report on Friday, October 9th. Sanford C. Bernstein reissued a “market perform” rating on shares of Stryker in a research report on Wednesday, October 7th. Weiss Ratings restated a “hold (c)” rating on shares of Stryker in a research note on Thursday, October 29th. Finally, UBS Group reduced their price objective on Stryker from $400.00 to $382.00 and set a “buy” rating for the company in a research report on Monday, August 3rd. Twenty-one equities research analysts have rated the stock with a Buy rating and seven have given a Hold rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $343.77.
Get Our Latest Analysis on SYK
About Stryker
Stryker is a medical technology company that develops and sells products and services for healthcare providers. Its offerings include orthopedic implants and surgical equipment, neurotechnology and spine products, and medical and surgical equipment used in hospitals and other care settings. The company’s products also include patient-handling and emergency medical equipment, as well as instruments and technologies that support surgical procedures. Stryker serves healthcare customers in the United States and internationally.
Featured Stories
- Five stocks we like better than Stryker
- ZIM Just Posted Huge Profits, But Its $35 Buyout Is Still in Limbo
- Owens Corning’s Stock Slump May Have a Silver Lining for Dividend Investors
- The Patchpocalypse Could Be a Big Opportunity for These 2 Cybersecurity Stocks
- Anthropic’s Record IPO Could Ease a Major Concern for Broadcom Investors
Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK – Free Report).
Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.
